Muscular dystrophies are inherited, progressive muscle disorders resulting from defects in one or more genes needed for normal muscle structure and function; dystrophic changes (eg, muscle fiber necrosis and regeneration) are seen on biopsy specimens.
Emery-Dreifuss dystrophy can be inherited as an autosomal dominant, autosomal recessive (the rarest), or X-linked recessive disorder. The overall incidence is unknown. Females can be carriers, but only males are affected clinically by X-linked inheritance.
Genes associated with Emery-Dreifuss dystrophy encode for the nuclear membrane proteins
Muscle weakness and wasting can begin any time before age 20 and commonly affect the biceps and triceps and, less often, distal leg muscles. Early contractures are characteristic. The heart is frequently involved, with atrial paralysis, conduction abnormalities (atrioventricular block), cardiomyopathy, and a high likelihood of sudden death.
Diagnosis of Emery-Dreifuss dystrophy is indicated by clinical findings, age at onset, and family history.
The diagnosis is supported by mildly increased serum creatine kinase levels and myopathic features on electromyography. Mutation analysis of DNA from peripheral blood leukocytes is the primary confirmatory test. If genetic testing does not confirm the diagnosis, then muscle biopsy can be done.
Treatment of Emery-Dreifuss dystrophy involves therapy to prevent contractures.
Cardiac pacemakers are sometimes lifesaving in patients with abnormal cardiac conduction.
The following are some English-language resources that may be useful. Please note that THE MANUAL is not responsible for the content of these resources.
Muscular Dystrophy Association: Information on research, treatment, technology, and support for patients living with Emery-Dreifuss muscular dystrophy
National Organization for Rare Disorders: Comprehensive information regarding Emery-Dreifuss muscular dystrophy, including standard and investigational therapies and links to related topics